Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04997356 · ClinicalTrials.gov registry record · NA

Hostile Bias Modification Training (HBMT) Study

A NA study of Stress and Aggression, sponsored by Walter Reed Army Institute of Research (WRAIR).

Completed
Registry status
NA
Development phase
165
Enrollment target
1
Study location

NCT04997356 is a NA study of Stress and Aggression that has completed, run by Walter Reed Army Institute of Research (WRAIR). The registered enrollment target is 165 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04997356, a NA study of Stress and Aggression, has completed, sponsored by Walter Reed Army Institute of Research (WRAIR).

COMPLETED
Registry status
NA
Development phase
165 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the present protocol is to evaluate the effectiveness of real HBMT versus placebo on reducing HAB and aggression. The secondary objectives of the present protocol are: 1. Investigate the role of individual difference variables on HAB, interpersonal aggression, and effects of HBMT. 2. Collect vocal recording data to inform the development of algorithms to predict emotional stress from changes in speech.

Interventions

  • BEHAVIORAL Hostile Bias Modification Training
  • BEHAVIORAL Other training

Study Locations (1)

Maryland

  • Walter Reed Army Institute of Research - Silver Spring

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2021-08-12
Est. Completion 2023-05-15
Phase NA

What the Registry Record Tells You About NCT04997356

The ClinicalTrials.gov registry entry for NCT04997356 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 152 other Stress trials with a reported enrollment target (79% lower). The listed sponsor is Walter Reed Army Institute of Research (WRAIR), which has 12 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Hostile Bias Modification Training is the first listed.

NCT04997356 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04997356 about?

NCT04997356 is a clinical study titled "Hostile Bias Modification Training (HBMT) Study". The primary objective of the present protocol is to evaluate the effectiveness of real HBMT versus placebo on reducing HAB and aggression. The secondary objectives of the present protocol are: 1. Investigate the role of individual difference variables on HAB, interpersonal aggression, and effects ...

What is the current status of trial NCT04997356?

This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2021-08-12. Estimated completion is 2023-05-15.

What conditions does trial NCT04997356 study?

This clinical trial studies the following conditions: Stress, Aggression, Anger.

What interventions are being tested in trial NCT04997356?

The interventions under investigation include: Hostile Bias Modification Training (BEHAVIORAL), Other training (BEHAVIORAL).

Who is sponsoring clinical trial NCT04997356?

This trial is sponsored by Walter Reed Army Institute of Research (WRAIR), which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04997356 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.